We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-6.9%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.88B
AUM Growth
-$154M
Cap. Flow
+$19.9M
Cap. Flow %
1.06%
Top 10 Hldgs %
16.6%
Holding
823
New
81
Increased
382
Reduced
295
Closed
54
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
51
Automatic Data Processing
ADP
$108B
$8.3M 0.44%
36,465
+6,381
+21% +$1.37M
UNH icon
52
UnitedHealth
UNH
$367B
$8.28M 0.44%
16,233
+343
+2% +$165K
ADBE icon
53
Adobe
ADBE
$106B
$7.92M 0.42%
17,393
-334
-2% -$161K
JNJ icon
54
Johnson & Johnson
JNJ
$624B
$7.91M 0.42%
44,618
+8,782
+25% +$1.49M
CMI icon
55
Cummins
CMI
$87.6B
$7.87M 0.42%
38,389
+5,051
+15% +$1.09M
UPS icon
56
United Parcel Service
UPS
$88.4B
$7.73M 0.41%
36,065
-3,446
-9% -$732K
ZTS icon
57
Zoetis
ZTS
$31B
$7.61M 0.4%
40,372
+2,956
+8% +$584K
SRLN icon
58
State Street Blackstone Senior Loan ETF
SRLN
$5.35B
$7.54M 0.4%
167,673
+86,566
+107% +$3.91M
ENTA icon
59
Enanta Pharmaceuticals
ENTA
$387M
$7.44M 0.4%
104,494
+2,430
+2% +$158K
CVS icon
60
CVS Health
CVS
$119B
$7.44M 0.4%
73,468
+964
+1% +$101K
WEC icon
61
WEC Energy
WEC
$34.7B
$7.34M 0.39%
73,558
-386
-0.5% -$36.5K
MDGL icon
62
Madrigal Pharmaceuticals
MDGL
$12.3B
$7.24M 0.38%
73,734
+4,473
+6% +$377K
MUE
63
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$7.18M 0.38%
594,213
+12,532
+2% +$158K
UTHR icon
64
United Therapeutics
UTHR
$22.6B
$6.83M 0.36%
38,093
-1,467
-4% -$279K
MFL
65
DELISTED
BLACKROCK MUNIHOLDINGS INVESTMENT QUALITY FUND
MFL
$6.83M 0.36%
556,829
-20,189
-3% -$265K
ALL icon
66
Allstate
ALL
$67.7B
$6.72M 0.36%
48,540
+710
+1% +$89.1K
ADI icon
67
Analog Devices
ADI
$188B
$6.68M 0.36%
40,446
-2,972
-7% -$482K
EVN
68
Eaton Vance Municipal Income Trust
EVN
$429M
$6.61M 0.35%
558,450
+30,915
+6% +$388K
ISRG icon
69
Intuitive Surgical
ISRG
$141B
$6.56M 0.35%
21,755
+3,769
+21% +$1.1M
TGT icon
70
Target
TGT
$69B
$6.55M 0.35%
30,884
+3,059
+11% +$662K
SUPN icon
71
Supernus Pharmaceuticals
SUPN
$2.8B
$6.55M 0.35%
202,682
-14,360
-7% -$440K
MRNA icon
72
Moderna
MRNA
$23.8B
$6.24M 0.33%
36,194
-1,303
-3% -$219K
ELV icon
73
Elevance Health
ELV
$84.6B
$6.2M 0.33%
12,623
+784
+7% +$358K
DE icon
74
Deere & Co
DE
$167B
$6.08M 0.32%
14,635
-5,530
-27% -$2.12M
APLS
75
DELISTED
Apellis Pharmaceuticals
APLS
$6.06M 0.32%
119,322
-17,438
-13% -$770K

Similar funds

Hennion & Walsh Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Hennion & Walsh Asset Management held 823 positions worth $1.88B, down 7.6% from $2.04B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hennion & Walsh Asset Management's Q1 2022 filing shows 81 new, 382 increased, 295 reduced and 54 closed positions. Its largest new stake was Vanguard S&P Small-Cap 600 ETF: 99,010 shares worth $9.8M. The largest sale was WisdomTree Emerging Markets ex-State-Owned Enterprises Fund, an estimated $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

  • Hennion & Walsh Asset Management's largest Q1 2022 buy was Vanguard S&P Small-Cap 600 ETF: 99,010 shares worth $9.8M.
  • Hennion & Walsh Asset Management added most to iShares Core MSCI Emerging Markets ETF in Q1 2022, an estimated $17.4M increase.
  • Hennion & Walsh Asset Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $3.49M.
  • Hennion & Walsh Asset Management fully exited WisdomTree Emerging Markets ex-State-Owned Enterprises Fund in Q1 2022, selling an estimated $13.6M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.88B portfolio in Q1 2022.
  • Hennion & Walsh Asset Management opened 81 new positions and closed 54 in Q1 2022.
  • Hennion & Walsh Asset Management's portfolio value fell 7.6% quarter-over-quarter to $1.88B.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2022, filed 26 Apr 2022.